Losortan Potassium
Product Images NDC 21695-989

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losortan Potassium (NDC 21695-989). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Losartan (41a61cf1 30a3 472b A592 B17a610daaba 01)

Chemical structure of losartan potassium showing the molecular arrangement of atoms including chlorine, nitrogen, hydroxyl, and potassium ion components as presented in the diagram.*

FDA Label Image

Structured Formula For Losartan (41a61cf1 30a3 472b A592 B17a610daaba 02)

A line chart comparing the percentage of patients with a primary endpoint over a 66-month study period for Losartan Potassium and Atenolol. The y-axis shows the percentage of patients, and the x-axis shows study months. Losartan Potassium shows a lower cumulative percentage than Atenolol, with an adjusted risk reduction of 13% and p=0.021.*

FDA Label Image

Structured Formula For Losartan (41a61cf1 30a3 472b A592 B17a610daaba 03)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over 66 months between Atenolol (dashed line) and Losartan Potassium (solid line). The graph indicates a 25% adjusted risk reduction for Losartan Potassium with a p-value of 0.001.*

FDA Label Image

Structured Formula For Losartan (41a61cf1 30a3 472b A592 B17a610daaba 04)

A forest plot figure comparing the hazard ratios of Losartan-K versus Atenolol for primary composite and stroke (fatal/non-fatal) events. It presents event rates by various subgroups including age, gender, race, ischemic heart status, diabetes, and history of cardiovascular disease, showing relative favorability between the two treatments.*

FDA Label Image

Structure Product Formula For Losartan (41a61cf1 30a3 472b A592 B17a610daaba 05)

A line graph showing the percentage of patients with an event over 48 months comparing Losartan Potassium Tablet and placebo. The graph indicates a 16.1% risk reduction with Losartan Potassium, with data points plotted over time up to 48 months.*

FDA Label Image

Losartan Potassium 25mg (41a61cf1 30a3 472b A592 B17a610daaba 06)

Losartan Potassium 25mg tablets label with quantity #30 from Physician Partner, distributed by Rebel Distributors Corp. The label includes the active ingredient strength and identification marks on tablets. Manufactured by Cadila Healthcare Ltd., Ahmedabad, India. Storage instructions and caution for keeping medication out of children's reach are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.